Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Research Support, Non-U.S. Gov't

Review

Clinical Trial

Comparative Study

Multicenter Study

Publication Year

From

Quick links

Individual year

2021

2016

2013

2012

2010

2009

2006

2004

2003

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Vardenafil Dihydrochloride""[mesh_terms]

10 Results

Searching titles within these results

Pharmacokinetics, pharmacodynamics, and efficacy of phosphodiesterase type 5 inhibitors.

David O Sussman

The Journal of the American Osteopathic Association 2004;104(3 Suppl 4):S11-5

Full Text

Abstract

Acute vasodilator response to vardenafil and clinical outcome in patients with pulmonary hypertension.

Anna Sandqvist, Dan Henrohn, Gerhard Wikström, Jörn Schneede, Ulf Bondesson, Lisa Wernroth, Mikael Hedeland, Hanna Egeröd

European journal of clinical pharmacology 2016;71(10):1165-73

Full Text

Abstract

Effect of propionyl-L-carnitine, L-arginine and nicotinic acid on the efficacy of vardenafil in the treatment of erectile dysfunction in diabetes.

Vincenzo Gentile, Gabriele Antonini, Maria Antonella Bertozzi, Nicola Dinelli, Cosimo Rizzo, Mohamed Ashraf Virmani, Aleardo Koverech

Current medical research and opinion 2009;25(9):2223-8

Full Text

Abstract

Erectile dysfunction in the cardiac patient: how common and should we treat?

Robert A Kloner, Stephanie H Mullin, Thomas Shook, Ray Matthews, Guy Mayeda, Steve Burstein, Harry Peled, Charles Pollick, Ranji Choudhary, Raymond Rosen, Harin Padma-Nathan

The Journal of urology 2003;170(2 Pt 2):S46-50; discussion S50

Full Text

Abstract

Identification and experimental confirmation of novel cGMP efflux inhibitors by virtual ligand screening of vardenafil-analogues.

Erik Sveberg Dietrichs, Istvan Enyedy, Roy Lyså, Georg Sager, Aina Ravna, Farzane Kuresh Kashgari

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2021;126():110109

Free Full Text

Abstract

Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.

Robert A Kloner

The American journal of cardiology 2006;96(12B):42M-46M

Full Text

Abstract

Response to on-demand vardenafil was improved by its daily usage in hypertensive men.

Valter Javaroni, Marcio Queiroz Miguez, Adriana Burla, Wille Oigman, Mario Fritsch Neves

Urology 2012;80(4):858-64

Full Text

Abstract

Efficacy of phosphodiesterase type 5 inhibitor treatment in men with erectile dysfunction and dyslipidemia: a post hoc analysis of the vardenafil statin study.

Martin M Miner, Allison Barnes, Stephen Janning

The journal of sexual medicine 2010;7(5):1937-47

Full Text

Abstract

PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.

Mauro Gacci, Gabriella Nesi, Sandra Filippi, Mario Maggi, Sergio Serni, Marco Carini, Ilaria Cellai, Linda Vignozzi, Annamaria Morelli, Elena Maneschi, Paolo Comeglio, Raffaella Santi, Arcangelo Sebastianelli

The Prostate 2013;73(13):1391-402

Full Text

Abstract

Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction.

Prabhu Rajagopalan, Arthur Mazzu, Chenghua Xia, Ray Dawkins, Pavur Sundaresan

Journal of clinical pharmacology 2003;43(3):260-7

Full Text

Abstract

Results: 1 – 10 / 10

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Vardenafil Dihydrochloride""[mesh_terms]

Pharmacokinetics, pharmacodynamics, and efficacy of phosphodiesterase type 5 inhibitors.

Acute vasodilator response to vardenafil and clinical outcome in patients with pulmonary hypertension.

Effect of propionyl-L-carnitine, L-arginine and nicotinic acid on the efficacy of vardenafil in the treatment of erectile dysfunction in diabetes.

Erectile dysfunction in the cardiac patient: how common and should we treat?

Identification and experimental confirmation of novel cGMP efflux inhibitors by virtual ligand screening of vardenafil-analogues.

Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.

Response to on-demand vardenafil was improved by its daily usage in hypertensive men.

Efficacy of phosphodiesterase type 5 inhibitor treatment in men with erectile dysfunction and dyslipidemia: a post hoc analysis of the vardenafil statin study.

PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.

Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction.

Results for
""Vardenafil Dihydrochloride""[mesh_terms]